Hong Kong has officially joined the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) as its 20th regulatory member. This early admission is expected to accelerate the development of Hong Kong's own drug regulatory authority, positioning the city as a key link for Chinese pharmaceuticals entering global markets. The move was announced following an assembly meeting in Prague. AI
RANK_REASON A city joining a significant international regulatory body for pharmaceuticals. [lever_c_demoted from significant: ic=1 ai=0.0]
- Centre for Health Innovation
- Centre for Medical Innovation
- Centre for Pharmaceutical and Medical Device Regulatory Affairs
- Hong Kong
- Hong Kong Science Park
- Hong Kong University of Science and Technology
- International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use
- Pharmaceuticals and Medical Devices Regulatory Affairs Committee
- The Chinese University of Hong Kong
- University of Hong Kong
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →